New Delhi, Jan 3: The Drugs Controller General of India (DCGI) on Sunday approved the emergency use of Bharat Biotech’s indigenously manufactured Corona vaccine ‘Covaxin’ and ‘Covishield’ manufactured by Serum Institute of India, Pune.
Briefing the media on COVID-19 vaccine, Drugs Controller General of India VG Somani said vaccines of Serum Institue of India and Bharat Biotech are granted permission for restricted use in emergency situation.
He said after adequate examination, the Central Drugs Standards Control Organisation (CDSCO) has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situation and permission is being granted to M/s Cadila Healthcare for conduct of the Phase III clinical trial.